Race, ethnicity has no impact on long-term mortality in T2DM

Race/Ethnicity has no impact on long-term mortality in T2DM

(HealthDay)—For adults with type 2 diabetes and coronary artery disease, race/ethnicity has no significant impact on the long-term risk of death, according to a study published in the Nov. 1 issue of The American Journal of Cardiology.

As part of the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial, Nirat Beohar, M.D., from Columbia University in Miami Beach, and colleagues examined the impact of race/ethnicity on control and on clinical outcomes in a setting with comparable access to medical care. A total of 1,750 adults with and from the United States and Canada were enrolled in the BARI 2D trial, and included 1,189 non-Hispanic whites, 349 non-Hispanic blacks, and 212 Hispanics. Participants were randomized to receive cardiac and glycemic treatment strategies.

During an average follow-up of 5.3 years, the researchers observed no significant variation by race/ethnicity in the long-term risk of death and death/myocardial infarction/stroke (five-year death: 11.0 percent whites; 13.7 percent blacks; 8.7 percent Hispanics; P = 0.19). For the 1,168 patients with suboptimal risk factor control at baseline, higher five-year survival was associated with the ability to attain better risk factor control (71, 86, and 95 percent, respectively, for patients with one, two, or three factors in control); this pattern was seen for all race/ethnicities.

"In conclusion, significant race/ethnic differences in cardiac risk profiles that persisted during follow-up did not translate into significant differences in five-year death or death/myocardial infarction/stroke," the authors write.

The BARI 2D Trial received funding, medications, and supplies from pharmaceutical companies.

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Post-CABG risk of death increased for blacks with PAD

date Jul 01, 2013

(HealthDay)—For patients undergoing coronary artery bypass grafting (CABG), the risk of death is higher for those with peripheral artery disease (PAD), particularly for black versus white patients, according ...

Racial disparity in diabetes mostly due to lifestyle

date Jul 27, 2012

(HealthDay) -- For postmenopausal women there are large racial/ethnic differences in diabetes incidence, but these are mostly attributable to lifestyle factors, according to a study published online July 25 ...

Recommended for you

Cognitive impairment predicts worse outcome in heart failure

date May 24, 2015

Cognitive impairment predicts worse outcome in elderly heart failure patients, reveals research presented today at Heart Failure 2015 by Hiroshi Saito, a physiotherapist at Kameda Medical Centre in Kamogawa, Japan. Patients ...

1950s drug is future heart treatment

date May 22, 2015

Oxford University researchers have found a promising future treatment for heart disease, going back to a drug first developed in 1950.

Time is muscle in acute heart failure

date May 21, 2015

Urgent diagnosis and treatment in acute heart failure has been emphasised for the first time in joint recommendations published today in European Heart Journal.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.